Snowden Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$736K Sell
5,816
-27
-0.5% -$3.42K 0.02% 611
2025
Q1
$747K Sell
5,843
-494
-8% -$63.2K 0.02% 600
2024
Q4
$838K Buy
6,337
+121
+2% +$16K 0.03% 567
2024
Q3
$905K Sell
6,216
-167
-3% -$24.3K 0.03% 545
2024
Q2
$876K Buy
6,383
+130
+2% +$17.8K 0.03% 548
2024
Q1
$858K Buy
6,253
+1,960
+46% +$269K 0.03% 549
2023
Q4
$583K Buy
4,293
+301
+8% +$40.9K 0.02% 636
2023
Q3
$488K Sell
3,992
-1,712
-30% -$209K 0.02% 668
2023
Q2
$724K Buy
5,704
+72
+1% +$9.14K 0.03% 570
2023
Q1
$727K Buy
5,632
+3
+0.1% +$387 0.03% 563
2022
Q4
$739K Buy
5,629
+46
+0.8% +$6.04K 0.03% 535
2022
Q3
$652K Buy
5,583
+235
+4% +$27.4K 0.03% 554
2022
Q2
$629K Sell
5,348
-328
-6% -$38.6K 0.03% 543
2022
Q1
$739K Buy
5,676
+1,612
+40% +$210K 0.03% 516
2021
Q4
$620K Buy
4,064
+683
+20% +$104K 0.03% 414
2021
Q3
$547K Sell
3,381
-1,966
-37% -$318K 0.03% 512
2021
Q2
$875K Buy
5,347
+1,787
+50% +$292K 0.04% 401
2021
Q1
$536K Sell
3,560
-10,206
-74% -$1.54M 0.03% 476
2020
Q4
$2.09M Sell
13,766
-100
-0.7% -$15.1K 0.14% 205
2020
Q3
$1.88M Sell
13,866
-562
-4% -$76.1K 0.15% 191
2020
Q2
$1.97M Sell
14,428
-343
-2% -$46.9K 0.17% 178
2020
Q1
$1.59M Sell
14,771
-582
-4% -$62.7K 0.17% 177
2019
Q4
$1.85M Sell
15,353
-4,667
-23% -$562K 0.16% 184
2019
Q3
$1.99M Buy
20,020
+874
+5% +$87K 0.2% 159
2019
Q2
$2.09M Buy
19,146
+101
+0.5% +$11K 0.21% 159
2019
Q1
$2.13M Buy
19,045
+992
+5% +$111K 0.23% 149
2018
Q4
$1.74M Buy
18,053
+153
+0.9% +$14.8K 0.23% 161
2018
Q3
$2.18M Buy
17,900
+577
+3% +$70.4K 0.25% 129
2018
Q2
$1.9M Buy
17,323
+716
+4% +$78.6K 0.25% 133
2018
Q1
$1.77M Buy
16,607
+634
+4% +$67.7K 0.26% 137
2017
Q4
$1.71M Buy
15,973
+793
+5% +$84.7K 0.24% 136
2017
Q3
$1.69M Buy
15,180
+858
+6% +$95.4K 0.27% 119
2017
Q2
$1.48M Buy
14,322
+1,044
+8% +$108K 0.28% 124
2017
Q1
$1.3M Sell
13,278
-6,432
-33% -$629K 0.29% 120
2016
Q4
$1.74M Buy
19,710
+228
+1% +$20.2K 0.44% 72
2016
Q3
$1.88M Buy
19,482
+10,647
+121% +$1.03M 0.51% 63
2016
Q2
$758K Buy
8,835
+1,101
+14% +$94.4K 0.23% 152
2016
Q1
$672K Buy
+7,734
New +$672K 0.23% 147